✦ LIBER ✦

Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors

✍ Scribed by Kim, Y. J.; Kim, Y.-G.; Shim, T. S.; Koo, B. S.; Hong, S.; Lee, C.-K.; Yoo, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of patients with tub

✍ B. Denis; A. Lefort; R. M. Flipo; F. Tubach; M. Lemann; P. Ravaud; D. Salmon; X. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Comparative effectiveness of switching t

✍ Gomez-Reino, J. J.; Maneiro, J. R.; Ruiz, J.; Rosello, R.; Sanmarti, R.; Romero, 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 107 KB

Tuberculosis and tumour necrosis factor-

✍ A. Perlmutter; A. Mittal; A. Menter 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Multi-functional flow cytometry analysis

✍ Sauzullo, I.; Scrivo, R.; Mengoni, F.; Ermocida, A.; Coppola, M.; Valesini, G.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

O3 Success of an earlier recommended scr

✍ Anand N Malaviya; Sanjiv Kapoor; Shriram Garg; Roopa Rawat; Divya Aggarwal; Sadh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Successful resolution of pneumonia devel

✍ Erika Angelucci; Monica Cesarini; Piero Vernia 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB